HCV Treatment Failure in the Era of DAAs
Hepatitis C virus (HCV) has six well‐known genotypes in worldwide and has a very high genetic diversity. Introduction of DAAs leads to improvement of treatment results with SVR rates exceeding 95%. Development of HCV treatment resistance is a problematic issue that needs sufficient solutions. Many h...
Saved in:
Main Authors: | Hassany, Mohamed (Author), Elsharkawy, Aisha (Author) |
---|---|
Format: | Ebooks |
Published: |
IntechOpen,
2017-03-08.
|
Subjects: | |
Online Access: | Get Online |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HCV and Drug Use - What Can Be Learned from the Failure to Control This Epidemic?
by: Philippe Chossegros
Published: (2012) -
Current Therapeutic Options for HCV-HIV Coinfection
by: Perić, Ljiljana, et al.
Published: (2017) -
Chronic HCV Infection: Clinical Advances and Eradication Perspectives
Published: (2022) -
Invasive Treatment in Advanced (Stage-D) Heart Failure
by: Kırali, Kaan, et al.
Published: (2017) -
TANGGUNG JAWAB PELAKU USAHA PERKEBUNAN KELAPA SAWIT TERHADAP AREA HIGH CONCERVATION VALUE (HCV)
by: PUTRA, Reiyan Novandana Syanur
Published: (2017)